| What is the difference between hypothyroidism and hyperthyroidism, and who is at risk for these conditions? [Journal Article]
Duke Med Health News 2009 Oct; 15(10):8.
Full Citation | | Stavrakis S, Yu X, Patterson E, et al.
Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.]
J Am Coll Cardiol 2009 Sep 29; 54(14):1309-16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jabrocka-Hybel A, Gołkowski F, Bałdys-Waligórska A, et al.
Graves' disease with an autonomously functioning thyroid nodule: case report. [Journal Article]
Pol Arch Med Wewn 2009 Jul-Aug; 119(7-8):505-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Polkowska E, Bossowski A
[The role of lymphocytes and secrete cytokines in autoimmune thyroid diseases.] [English Abstract, Journal Article]
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2009; 15(2):114-7.
Abstract | Full Citation | Find Related Articles | | Bednarczuk T, Bar-Andziak E, Wsp AH
[Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement.] [JOURNAL ARTICLE]
Endokrynol Pol 2009; 60(4):312-330.
Full Citation | Find Related Articles | | Douglas RS, Tsirbas A, Gordon M, et al.
Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Arch Ophthalmol 2009 Sep; 127(9):1155-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kochetkov PA, Lopatin AS, Sergienko NI
[Endonasal endoscopic orbital decompression through the transethmoidal approach.] [JOURNAL ARTICLE]
Vestn Otorinolaringol 2009; (4):23-26.
Abstract | Full Citation | Find Related Articles | | Leo M, Pinchera A, Marcocci C
Orbital lymphoma masquerading as thyroid-associated orbitopathy. [Case Reports, Journal Article]
J Clin Endocrinol Metab 2009 Sep; 94(9):3155-6.
Full Citation | Publisher Full Text | | Daroszewski J, Pawlak E, Karabon L, et al.
Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 JO31 and CT60 gene polymorphisms. [JOURNAL ARTICLE]
Eur J Endocrinol 2009 Sep 4.
Abstract | Full Citation | | Träisk F, Tallstedt L, Abraham-Nordling M, et al.
Thyroid-Associated Ophthalmopathy after Treatment for Graves' Hyperthyroidism with Antithyroid Drugs or Iodine-131. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2009 Sep 1.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
